Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Lower BDNF levels link to worse depression in alopecia areata patients.

Certain gene variations may increase the risk and severity of alopecia areata.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Better models and evaluation methods for alopecia areata are needed.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

PGD2 stops hair growth and is higher in bald men with AGA.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Effective treatments for severe alopecia areata are still lacking.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Microneedling helped two Pomeranian dogs with a hair growth disorder grow back 90% of their fur in 12 weeks, and the results lasted for a year.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.